Pamela Kearns
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 13
- Oncology top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 17
- Glioma Diagnosis and Treatment 8
-
- Childhood Cancer Survivors' Quality of Life 35
- Pharmaceutical studies and practices 10
- Ethics and Legal Issues in Pediatric Healthcare 10
- Neurology top 5%
- Neuroblastoma Research and Treatments 16
-
- Acute Lymphoblastic Leukemia research 45
- Co-authors
- Charlotte V. CoxAllison BlairRoger S. EvelyAndrew D.J. PearsonTracey PerryVictoria WestonGilles VassalGuy Pratt
- Cited by
- HematologyOncologyGenetics
- Journals
- Blood (21 papers)Journal of Clinical Oncology (13 papers)Pediatric Blood & Cancer (9 papers)
- Partner nations
- United KingdomNetherlandsFrance
In The Last Decade
Pamela Kearns
110 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 119
- Hematology 487
- Oncology 837
- Genetics 318
- Pediatrics, Perinatology and Child Health 382
- Neurology 276
Countries citing papers authored by Pamela Kearns
This map shows the geographic impact of Pamela Kearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Kearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Kearns more than expected).
Fields of papers citing papers by Pamela Kearns
This network shows the impact of papers produced by Pamela Kearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Kearns. The network helps show where Pamela Kearns may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pamela Kearns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 90 | |
| 11 | 2020 | 24 | |
| 12 | 2019 | 23 | |
| 13 | 2019 | 10 | |
| 14 | 2018 | 5 | |
| 15 | 2013 | 66 | |
| 16 | 2011 | 12 | |
| 17 | The plasma and intracellular pharmacokinetics of clofarabine in pediatric leukemia patients | 2007 | 2 |
| 18 | Investigation of urotensin-II converting enzyme activity in human cells and blood | 2004 | 1 |
| 19 | 2003 | 2 | |
| 20 | 2002 | 21 |
About Pamela Kearns
Pamela Kearns is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 116 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (45 papers), Childhood Cancer Survivors' Quality of Life (35 papers), Chronic Lymphocytic Leukemia Research (17 papers), Neuroblastoma Research and Treatments (16 papers), Chronic Myeloid Leukemia Treatments (13 papers), Pharmaceutical studies and practices (10 papers), Ethics and Legal Issues in Pediatric Healthcare (10 papers) and Glioma Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (487 citations), Oncology (837 citations) and Genetics (318 citations). Pamela Kearns has collaborated with scholars based in United Kingdom, Netherlands and France. Frequent co-authors include Charlotte V. Cox, Allison Blair, Roger S. Evely, Andrew D.J. Pearson, Tracey Perry, Victoria Weston, Gilles Vassal, Guy Pratt, Andrew G. Hall and Tatjana Stanković. Their work appears in journals such as Blood, Journal of Clinical Oncology, Pediatric Blood & Cancer, European Journal of Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.